CYP3A5 inhibition causes G1/S blockade and synergizes with CDK4/6 inhibitor to suppress prostate cancer cell growth: Implications in reducing health disparity

Jeetesh Sharma(Roseman University of Health Sciences), Ranjana Mitra(Roseman University of Health Sciences)

bioRxiv (Cold Spring Harbor Laboratory)

October 3, 2024

10.1101/2024.10.01.616176

Cited by 0

Related Papers

Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5

|BMC Cancer|2017|72

Bergamottin a CYP3A inhibitor found in grapefruit juice inhibits prostate cancer cell growth by downregulating androgen receptor signaling and promoting G0/G1 cell cycle block and apoptosis

|PLoS ONE|2021|10

Role of CYP3A5 in modulating androgen receptor signaling and its relevance to African American men with prostate cancer

|bioRxiv (Cold Spring Harbor Laboratory)|2020|2